PubMed for id: 1519315217

Year	Number of Results
1995	3
1996	1
1997	1
2022	1
2023	4
2024	2

1

ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.

Jamann H, Desu HL, Cui QL, Halaweh A, Tastet O, Klement W, Zandee S, Pernin F, Mamane VH, Ouédraogo O, Daigneault A, Sidibé H, Millette F, Peelen E, Dhaeze T, Hoornaert C, Rébillard RM, Thai K, Grasmuck C, Vande Velde C, Prat A, Arbour N, Stratton JA, Antel J, Larochelle C. Jamann H, et al. Brain. 2024 Jan 4;147(1):147-162. doi: 10.1093/brain/awad286. Brain. 2024. PMID: 37640028

2

Clinical significance of CD166 and HER-2 in different types of gastric cancer.

Moradi L, Tajik F, Saeednejad Zanjani L, Panahi M, Gheytanchi E, Biabanaki ZS, Kazemi-Sefat GE, Hashemi F, Dehghan Manshadi M, Madjd Z. Moradi L, et al. Clin Transl Oncol. 2024 Mar;26(3):664-681. doi: 10.1007/s12094-023-03297-0. Epub 2023 Aug 3. Clin Transl Oncol. 2024. PMID: 37537510

3

Expression of ALCAM in Clinical Colon Cancer and Relationship With Patients' Treatment Responses.

Fang Z, Zeng JJ, Yang Y, Ruge F, Lane J, Hargest R, Jiang WG. Fang Z, et al. In Vivo. 2023 May-Jun;37(3):1117-1128. doi: 10.21873/invivo.13187. In Vivo. 2023. PMID: 37103072 Free PMC article.

4

ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient's Response to Chemotherapies.

Yang YM, Ruge F, Ji KE, Jia S, Jia Y, Sanders AJ, Ji J, Jiang WG. Yang YM, et al. Anticancer Res. 2023 Apr;43(4):1463-1475. doi: 10.21873/anticanres.16295. Anticancer Res. 2023. PMID: 36974802

5

Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer's disease.

Chen J, Dai AX, Tang HL, Lu CH, Liu HX, Hou T, Lu ZJ, Kong N, Peng XY, Lin KX, Zheng ZD, Xu SL, Ying XF, Ji XY, Pan H, Wu J, Zeng X, Wei NL. Chen J, et al. Front Immunol. 2023 Jan 4;13:1097409. doi: 10.3389/fimmu.2022.1097409. eCollection 2022. Front Immunol. 2023. PMID: 36685605 Free PMC article.

6

CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.

Singer NG, Mitra R, Lialios F, Richardson BC, Marks RM, Pesando JM, Fox DA, Nickoloff BJ. Singer NG, et al. Immunol Lett. 1997 Jun;58(1):9-14. doi: 10.1016/s0165-2478(97)02707-7. Immunol Lett. 1997. PMID: 9436462

7

Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.

Skonier JE, Bowen MA, Emswiler J, Aruffo A, Bajorath J. Skonier JE, et al. Biochemistry. 1996 Sep 24;35(38):12287-91. doi: 10.1021/bi961038k. Biochemistry. 1996. PMID: 8823162

8

Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.

Bajorath J, Bowen MA, Aruffo A. Bajorath J, et al. Protein Sci. 1995 Aug;4(8):1644-7. doi: 10.1002/pro.5560040822. Protein Sci. 1995. PMID: 8520490 Free PMC article.

9

Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.

Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U, et al. Bowen MA, et al. J Exp Med. 1995 Jun 1;181(6):2213-20. doi: 10.1084/jem.181.6.2213. J Exp Med. 1995. PMID: 7760007 Free PMC article.

10

The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.

Whitney GS, Starling GC, Bowen MA, Modrell B, Siadak AW, Aruffo A. Whitney GS, et al. J Biol Chem. 1995 Aug 4;270(31):18187-90. doi: 10.1074/jbc.270.31.18187. J Biol Chem. 1995. PMID: 7543097 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year